Cleared Traditional

K792513 - HEMODIALYSIS CONCENTRATE SOLUTION

K792513 is the FDA 510(k) clearance for HEMODIALYSIS CONCENTRATE SOLUTION by Mid Atlantic Nephrology Center. It is a Class 2 Gastroenterology & Urology device (product code KPO) cleared through the Traditional 510(k) pathway after a 125-day FDA review.

K792513 · Mid Atlantic Nephrology Center · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1980
Decision
125d
Days
Class 2
Risk

K792513 is an FDA 510(k) clearance for the HEMODIALYSIS CONCENTRATE SOLUTION. Classified as Dialysate Concentrate For Hemodialysis (liquid Or Powder) (product code KPO), Class II - Special Controls.

Submitted by Mid Atlantic Nephrology Center (Mchenry, US). The FDA issued a Cleared decision on April 8, 1980 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5820 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Mid Atlantic Nephrology Center devices

Submission Details

510(k) Number K792513 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1979
Decision Date April 08, 1980
Days to Decision 125 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d faster than avg
Panel avg: 130d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPO Dialysate Concentrate For Hemodialysis (liquid Or Powder)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KPO Dialysate Concentrate For Hemodialysis (liquid Or Powder)

All 52
Devices cleared under the same product code (KPO) and FDA review panel - the closest regulatory comparables to K792513.
NATURALYTE BICARBONATE DIALYSATE CONCEN.
K810925 · Erika, Inc. · Apr 1981
DIALYSATE CONCENTRATE FOR HEMODIALYSIS
K810280 · Cobe Laboratories, Inc. · Feb 1981
LOW-ACETATE HEMODIALYSIS BATH CONCENTR.
K800624 · Travenol Laboratories, S.A. · Jul 1980
RENAL SYSTEMS HEMODIALYSIS CONCENTRATE
K792213 · Renal Systems, Inc. · Jan 1980
HEMODIALYSIS CONCENTRATE, SODIU
K781967 · Renal Systems, Inc. · Dec 1978
DRI-LYTE
K780353 · Mallinckrodt Critical Care · Apr 1978